in

GSK and Sanofi partner on COVID-19 vaccine

The adjuvanted vaccine will be developed with Sanofi’s S-protein COVID-19 antigen and GSK’s pandemic adjuvant tech.

Source link

New color Face Mask Soft Fabric Reusable, Washable

Why COVID-19 Is a Special Danger to Otolaryngologists